z-logo
open-access-imgOpen Access
Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes
Author(s) -
Ildikò Szabó,
Albrecht LeppleWienhues,
Kristen N. Kaba,
Mario Zoratti,
Erich Gulbins,
Florian Läng
Publication year - 1998
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.95.11.6169
Subject(s) - fas receptor , jurkat cells , tyrosine kinase , microbiology and biotechnology , apoptosis , ceramide , receptor tyrosine kinase , kinase , intracellular , proto oncogene tyrosine protein kinase src , biology , tyrosine , tyrosine kinase inhibitor , signal transduction , programmed cell death , chemistry , biochemistry , t cell , immune system , immunology , cancer , genetics
CD95/Fas/APO-1 mediated apoptosis is an important mechanism in the regulation of the immune response. Here, we show that CD95 receptor triggering activates an outwardly rectifying chloride channel (ORCC) in Jurkat T lymphocytes. Ceramide, a lipid metabolite synthesized upon CD95 receptor triggering, also induces activation of ORCC in cell-attached patch clamp experiments. Activation is mediated by Src-like tyrosine kinases, because it is abolished by the tyrosine kinase inhibitor herbimycin A or by genetic deficiency of p56lck. In vitro incubation of excised patches with purified p56lck results in activation of ORCC, which is partially reversed upon addition of anti-phosphotyrosine antibody. Inhibition of ORCC by four different drugs correlates with a 30-65% inhibition of apoptosis. Intracellular acidification observed upon CD95 triggering is abolished by inhibition of either ORCC or p56lck. The results suggest that tyrosine kinase-mediated activation of ORCC may play a role in CD95-induced cell death in T lymphocytes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom